University of California, David Clinical & Translational Science Center Clinical Research (CCRC) — Sacramento, California

University of California, David Clinical & Translational Science Center Clinical Research (CCRC) is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, David Clinical & Translational Science Center Clinical Research (CCRC) has participated in 1 clinical trials.

Therapeutic areas: Focal Onset Seizures.

Sponsors: Xenon Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, David Clinical & Translational Science Center Clinical Research (CCRC)?

University of California, David Clinical & Translational Science Center Clinical Research (CCRC) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, David Clinical & Translational Science Center Clinical Research (CCRC) conducted?

University of California, David Clinical & Translational Science Center Clinical Research (CCRC) has 1 clinical trials on record. Their work covers Focal Onset Seizures.

Is University of California, David Clinical & Translational Science Center Clinical Research (CCRC) accredited by Crixeo Health?

University of California, David Clinical & Translational Science Center Clinical Research (CCRC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, David Clinical & Translational Science Center Clinical Research (CCRC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.